tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Heather Behanna, 16 are a BUY (55.17%), 13 are a HOLD (44.83%).
Analyst Heather Behanna, carries an average stock price target met ratio of 95.83% that have a potential upside of 60.33% achieved within 491 days. Previously, Heather Behanna worked at WEDBUSH.
Heather Behanna’s has documented 58 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ALXN, Alexion Pharmaceuticals at 12-Dec-2016.
Analyst best performing recommendations are on TTPH (TETRAPHASE PHARMACEUTICALS).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 5/20/2015. The price target of $25 was fulfilled within 1 day with a profit of $1.24 (4.73%) receiving and performance score of 47.26.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 23-Jun-2025
$20
$-0.11 (-0.55%)
$16
2 months 12 days ago
(09-Jul-2026)
7/17 (41.18%)
$-0.52 (-2.53%)
71
Sell Since 24-Jul-2025
$13
$-3.85 (-22.85%)
5 months 26 days ago
(26-Mar-2026)
0/2 (0%)
$-8.68 (-40.04%)
Sell Since 22-Jul-2025
5 months 26 days ago
(26-Mar-2026)
14/35 (40%)
$28.03 (127.58%)
364
Buy Since 19-Mar-2026
$37
$20.15 (119.58%)
$50
6 months 2 days ago
(19-Mar-2026)
0/16 (0%)
$20.35 (122.22%)
Buy Since 13-Mar-2026
$31
$14.15 (83.98%)
$19
6 months 8 days ago
(13-Mar-2026)
4/14 (28.57%)
$14.6 (89.02%)
322
